Trial intelligence / Profile preview

Low vs high dose unfractionated heparin in off-pump coronary artery bypass surgery

2007-001443-22Phase 4Active

Sponsor
Policlinico di Bari
Start
Mar 2007
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of heparin in coronary arteriosclerosis (2 arms), sponsored by Policlinico di Bari. Primary endpoints: Endogenous thrombin potential (ETP) and Plasmatic level of PF1+2. Started Mar 2007; status: active.

02

Drugs

heparin
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2007-001443-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001443-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call